Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 4:22 PM
Ignite Modification Date: 2025-12-25 @ 2:17 PM
NCT ID: NCT05121766
Description: Self-reporting adverse events
Frequency Threshold: 0
Time Frame: During the 12 weeks of the treatment with omega-3/placebo
Study: NCT05121766
Study Brief: Feasibility Pilot Clinical Trial of Omega-3 Supplement vs. Placebo for Post Covid-19 Recovery Among Health Care Workers
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Study Arm - Omega 3 Supplement Omega-3 (EPA+DHA) - Dose is 2,100mg per day via 3 mini-capsules, 2x/day (a total of 6 mini-capsules per day). Each capsule has 252mg of EPA and 102mg of DHA. Omega-3 (EPA+DHA): Dose is 2,100mg per day via 3 mini-capsules, 2x/day (a total of 6 mini-capsules per day). Each capsule has 252mg of EPA and 102mg of DHA. 0 None 0 16 1 16 View
Control Arm - Placebo 3 Soybean Oil Placebo capsules 2x/day (a total of 6 mini-capsules per day). Placebo: 3 Soybean Oil Placebo capsules 0 None 0 16 5 16 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Excessive Fatigue NON_SYSTEMATIC_ASSESSMENT General disorders None View
Minimal bleeding NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Bloody nose NON_SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders None View
Localized pain NON_SYSTEMATIC_ASSESSMENT Nervous system disorders None View
Rash NON_SYSTEMATIC_ASSESSMENT Skin and subcutaneous tissue disorders None View
Diarrhea NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View